Amneal to transfer stock exchange listing from NYSE to Nasdaq effective Dec 27, 2023

Amneal Pharmaceuticals, Inc.

Listing on NYSE ends at market close Dec 26; Nasdaq trading starts at market open Dec 27.
Common stock will continue to trade under symbol AMRX and join Nasdaq Composite and Nasdaq Biotechnology Index.
Voluntary delisting from NYSE approved by Board; no change in business operations or shareholder rights.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.